Worst performer should have done much better on positive results, but SBTX:SkinBioTherapeutics are still quite a way off revenue so that possibly caused the 13% slide this week . These are now down by 34% since that exciting day when I bought them just seconds after the IPO. Bet if I hadn't bought them that day they would have soared! Sweetbiotix will undoubtedly soar the day that launches.
CWR:Ceres Power Holdings had a good week last week, climbing 6%, but this week dropped 9% to wipe out those gains.
WRES:W Resources looked like they might have turned a corner, but it was far too much to hope for as over 250 million shares were issued in yet another placing just after announcing that debt financing would cover remaining costs. I don't trust this company as far as I can throw the tungsten that they are so far failing to produce.
RED:RedT Energy only climbed 4% this week after the last 2 weeks as Share of the Week, but that was enough to take them into profit for the first time in ages.
Good news for ARL:Atlantis Resources which climbed 10% after an article was posted in the Daily Mail. It still leaves them down by 44% though, so a long way to go yet.
IQE:IQE recovered from the recent blip with a rise of 13% in my ISA, but these are going to have double digit movements nearly every week as I'm measuring rises and falls based on % of my purchase price of 29.5p.
Share of the Week was MTFB:Motif Bio with a staggering 36% rise after announcing the success of their phase III trial for Iclaprim. I'm quite surprised it didn't climb even further, although that would result in profit taking and a subsequent drop so maybe it's not a bad thing. Now it's just a case of seeing whether this will be allowed to create value or be bought out by a big boy while it's still cheap.
Seems like a while since the weekly movement was so small it doesn't really register on the graph.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £39.59 | -£3.75 | |
| Portfolio cost | £44,426.84 | +£0 | |
| Portfolio sell value (bid price - commission) | £48,041.86 | (+8.1%) | -£388.85 |
| Potential profits | £8,665.80 | +£70.54 | |
| Yr 3 Dividends | £0 | +£0 | |
| Yr 3 Profit from sales | £585.38 | +£0 | |
| Yr 3 Average monthly cash profit | £256.56 | (6.9%) | -£34.10 |
| Total Dividends | £1,179.05 | +£0 | |
| Total Profit from sales | £7,297.85 | +£0 | |
| Average monthly cash profit | £320.75 | (8.7%) | -£3.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to the monthly ISA fee, potential profits actually grew by £70 but the 3% drop in OPTI:Optibiotix sent that back into loss and contributed most to the drop.
Nothing alarming, just happy to be above the red line.
The SIPP looks like this after week 97
| Weekly Change | |||
| Cash | £44.63 | -£10.17 | |
| Portfolio cost | £25,218.51 | +£0 | |
| Portfolio sell value (bid price - commission) | £27,071.83 | (7.3%) | -£120.88 |
| Potential profits | £3,082.58 | -£244.06 | |
| Yr 2 Dividends | £328.84 | +£0 | |
| Yr 2 Profit from sales | £6,575.33 | +£0 | |
| Yr 2 Average monthly cash profit | £656.55 | (31.2%) | -£15.92 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £8,925.19 | +£0 | |
| Average monthly cash profit | £425.75 | (20.3%) | -£4.90 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to monthly fees, profits dropped twice as much as the weekly fall in value thanks to OPTI:Optibiotix and helped by the ARL:Atlantis Resources and IQE:IQE losses improving. CAML:Central Asia Metals survived the dividend ex-date intact and even managed to finish the week 3% up.
Remarkably similar to the previous graph.
The trading account looks like this after week 63
| Weekly Change | |||
| Cash | £79.63 | +£0 | |
| Portfolio cost | £486.05 | +£0 | |
| Portfolio sell value (bid price - commission) | £366.13 | (-24.7%) | -£5.56 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£0 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.49 | (-3.7%) | +£0.03 |
| (Sold stocks profit + Dividends - Fees / Months) |
There seemed to be much more positive momentum behind REDS:RedstoneConnect following a possible takeover bid, but that fizzled out when they claimed the approach was lacking in any detail and so wasn't being entertained. There's still no imminent prospect of me getting rid of these and so the account continues to languish in tedium.
Shame the top part of the graph isn't more symmetrical else it might look quite pretty in a few weeks.
Not much news anticipated during next week. REDS:RedstoneConnect are due to announce interims, so with the potential takeover saga that might be where most of the interest lies. Lots of potential surprises await though, as there's a heck of a lot happening for most of my holdings at the moment.
No comments:
Post a Comment